Additionally, monocytes – which express activating FcRs such as FcγRI (CD64) and FcγRIIa (CD32a) – have demonstrated the ability to eliminate tumor cells through ADCP as well (9–11). This evidence concerns the gene FCGR2A and neoplasm.